Search Results - "Fuller, John H"

Effects of Atorvastatin on Kidney Outcomes and Cardiovascular Disease in Patients With Diabetes: An Analysis From the Collaborative Atorvastatin Diabetes Study (CARDS) by Colhoun, Helen M., MD, Betteridge, D. John, PhD, Durrington, Paul N., MD, Hitman, Graham A., MD, Neil, H. Andrew W., DSc, Livingstone, Shona J., MSc, Charlton-Menys, Valentine, PhD, DeMicco, David A., PharmD, Fuller, John H., FRCP

“…Background We examined whether atorvastatin affects diabetic kidney disease and whether the effect of atorvastatin on cardiovascular disease (CVD) varies by…”
Get full text

Vascular Risk Factors and Diabetic Neuropathy by Tesfaye, Solomon, Chaturvedi, Nish, Eaton, Simon E.M, Ward, John D, Manes, Christos, Ionescu-Tirgoviste, Constantin, Witte, Daniel R, Fuller, John H

“…Apart from glycemic control, there is no treatment for diabetic neuropathy. Thus, identifying potentially modifiable risk factors is crucial for the…”
Get full text

Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a) by Deshmukh, Harshal A., Colhoun, Helen M., Johnson, Toby, McKeigue, Paul M., Betteridge, D. John, Durrington, Paul N., Fuller, John H., Livingstone, Shona, Charlton-Menys, Valentine, Neil, Andrew, Poulter, Neil, Sever, Peter, Shields, Denis C., Stanton, Alice V., Chatterjee, Aurobindo, Hyde, Craig, Calle, Roberto A., DeMicco, David A., Trompet, Stella, Postmus, Iris, Ford, Ian, Jukema, J. Wouter, Caulfield, Mark, Hitman, Graham A.

“…We carried out a genome-wide association study (GWAS) of LDL-c response to statin using data from participants in the Collaborative Atorvastatin Diabetes Study…”
Get full text

Glycemic Control and All-Cause Mortality Risk in Type 1 Diabetes Patients: The EURODIAB Prospective Complications Study by Schoenaker, Danielle A. J. M, Simon, Dominique, Chaturvedi, Nish, Fuller, John H, Soedamah-Muthu, Sabita S, the EURODIAB Prospective Complications Study Group

“…Context: Glycemic targets and the benefit of intensive glucose control are currently under debate because intensive glycemic control has been suggested to have…”
Get full text

Circulating matrix metalloproteinases are associated with arterial stiffness in patients with type 1 diabetes: pooled analysis of three cohort studies by Peeters, Stijn A, Engelen, Lian, Buijs, Jacqueline, Chaturvedi, Nish, Fuller, John H, Jorsal, Anders, Parving, Hans-Henrik, Tarnow, Lise, Theilade, Simone, Rossing, Peter, Schalkwijk, Casper G, Stehouwer, Coen D A

“…Altered regulation of extracellular matrix (ECM) composition by matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinase (TIMPs) may…”
Get full text

Large-Fiber Dysfunction in Diabetic Peripheral Neuropathy Is Predicted by Cardiovascular Risk Factors by Elliott, Jackie, Tesfaye, Solomon, Chaturvedi, Nish, Gandhi, Rajiv A, Stevens, Lynda K, Emery, Celia, Fuller, John H

“…OBJECTIVE: Diabetic large-nerve fiber dysfunction, as measured by vibration perception threshold (VPT), predicts foot ulceration, amputation, and mortality…”
Get full text

Relation Between Blood Glucose and Coronary Mortality Over 33 Years in the Whitehall Study by BRUNNER, Eric J, SHIPLEY, Martin J, WITTE, Daniel R, FULLER, John H, MARMOT, Michael G

“…Relation Between Blood Glucose and Coronary Mortality Over 33 Years in the Whitehall Study Eric J. Brunner , PHD , Martin J. Shipley , MSC , Daniel R. Witte ,…”
Get full text

Female sex is a risk factor for painful diabetic peripheral neuropathy: the EURODIAB prospective diabetes complications study by Elliott, Jackie, Sloan, Gordon, Stevens, Lynda, Selvarajah, Dinesh, Cruccu, Giorgio, Gandhi, Rajiv A., Kempler, Peter, Fuller, John H., Chaturvedi, Nishi, Tesfaye, Solomon

“…Aims/hypothesis While the risk factors for diabetic peripheral neuropathy (DPN) are now well recognised, the risk factors for painful DPN remain unknown. We…”
Get full text

Lipoprotein Subclasses and Particle Sizes and Their Relationship With Coronary Artery Calcification in Men and Women With and Without Type 1 Diabetes by COLHOUN, Helen M, OTVOS, James D, RUBENS, Mike B, TASKINEN, M. R, UNDERWOOD, S. Richard, FULLER, John H

“…Lipoprotein Subclasses and Particle Sizes and Their Relationship With Coronary Artery Calcification in Men and Women With and Without Type 1 Diabetes Helen M…”
Get full text

Anti–Heat Shock Protein 27 Antibody Levels and Diabetes Complications in the EURODIAB Study by BURT, Davina, BRUNO, Graziella, CHATURVEDI, Nish, SCHALKWIJK, Casper, STEHOUWER, Coen D, WITTE, Daniel R, FULLER, John H, PINACH, Silvia, CAVALLO PERIN, Paolo, GRUDEN, Gabriella

“…Anti–Heat Shock Protein 27 Antibody Levels and Diabetes Complications in the EURODIAB Study Davina Burt , PHD 1 , Graziella Bruno , MD 1 , Nish Chaturvedi ,…”
Get full text

MicroRNA-126 and micro-/macrovascular complications of type 1 diabetes in the EURODIAB Prospective Complications Study by Barutta, Federica, Bruno, Graziella, Matullo, Giuseppe, Chaturvedi, Nish, Grimaldi, Serena, Schalkwijk, Casper, Stehouwer, Coen D., Fuller, John H., Gruden, Gabriella

“…Aims Increasing evidence suggests a potential role of circulating miRNAs as clinical biomarkers, and loss of miRNA-126 has been proposed as a predictor of type…”
Get full text

Microalbuminuria in type 1 diabetes: Rates, risk factors and glycemic threshold by Chaturvedi, Nish, Bandinelli, Simona, Mangili, Ruggero, Penno, Guiseppe, Rottiers, Raoul E., Fuller, John H.

“…Microalbuminuria in type 1 diabetes: Rates, risk factors and glycemic threshold. The occurrence of microalbuminuria in type 1 diabetes is strongly predictive…”
Get full text

Incident cardiovascular disease by clustering of favourable risk factors in type 1 diabetes: the EURODIAB Prospective Complications Study by Soulimane, Soraya, Balkau, Beverley, Vogtschmidt, Yakima D., Toeller, Monika, Fuller, John H., Soedamah-Muthu, Sabita S.

“…Aims The aim of this prospective study was to examine CVD risk reduction in type 1 diabetes (1) for people with favourable cardiovascular health metrics and…”
Get full text

Differing Associations of Lipid and Lipoprotein Disturbances With the Macrovascular and Microvascular Complications of Type 1 Diabetes by CHATURVEDI, Nish, FULLER, John H, TASKINEN, Marja-Riitta

“…Differing Associations of Lipid and Lipoprotein Disturbances With the Macrovascular and Microvascular Complications of Type 1 Diabetes Nish Chaturvedi , MRCP 1…”
Get full text

The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS) by Newman, Connie B, Szarek, Michael, Colhoun, Helen M, Betteridge, D John, Durrington, Paul N, Hitman, Graham A, Neil, H Andrew W, Demicco, David A, Auster, Sheila, Fuller, John H

“…The objective of this study was to evaluate the safety and tolerability of atorvastatin 10 mg compared with placebo in 2,838 patients with type 2 diabetes and…”
Get more information

Total Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products as Predictive Biomarkers of Coronary Heart Disease Risk in Patients With Type 2 Diabetes: An Analysis From the CARDS Trial by COLHOUN, Helen M, JOHN BETTERIDGE, D, DESHMUKH, Harshal, TAN, Kathryn, FULLER, John H, DURRINGTON, Paul, HITMAN, Graham, NEIL, Andrew, LIVINGSTONE, Shona, CHARLTON-MENYS, Valentine, BAO, Weihang, DEMICCO, David A, PRESTON, Gregory M

“…Circulating levels of soluble receptor for advanced glycation end products (sRAGE) likely comprise both a secreted isoform (esRAGE) and wild-type RAGE cleaved…”
Get full text

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial by Colhoun, Helen M, Betteridge, D John, Durrington, Paul N, Hitman, Graham A, W Neil, H Andrew, Livingstone, Shona J, Thomason, Margaret J, Mackness, Michael I, Charlton-Menys, Valentine, Fuller, John H

“…Type 2 diabetes is associated with a substantially increased risk of cardiovascular disease, but the role of lipid-lowering therapy with statins for the…”
Get full text

Digital controller design for time-delayed Bouc-Wen hysteretic systems by Zhang, Jian, Zhang, Yongpeng, Ali, Warsame H., Fuller, John H., Shieh, Leang-san

“…Bouc-Wen model is a popular analytical form to describe hysteretic system while the non-smooth absolute-value function terms in the model bring about…”
Get full text

Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study by GRUDEN, Gabriella, BARUTTA, Federica, CHATURVEDI, Nish, SCHALKWIJK, Casper, STEHOUWER, Coen D, WITTE, Daniel R, FULLER, John H, CAVALLO PERIN, Paolo, BRUNO, Graziella

“…Frequent episodes of severe hypoglycemia may increase the risk of cardiovascular disease (CVD) in people with diabetes. Our aim was to study the relationship…”
Get full text

LADA and CARDS: A Prospective Study of Clinical Outcome in Established Adult-Onset Autoimmune Diabetes by MOHAMMED IQBAL HAWA, BUCHAN, Ana Paula, COLHOUN, Helen, LESLIE, Richard David, HITMAN, Graham A, OLA, Thomas, CHUAN CHUAN WUN, DEMICCO, David A, WEIHANG BAO, BETTERIDGE, D. John, DURRINGTON, Paul N, FULLER, John H, NEIL, H. Andrew W

“…Diabetes-associated autoantibodies can be detected in adult-onset diabetes, even when initially non-insulin requiring, i.e., with latent autoimmune diabetes…”
Get full text